Detection of a 67-kD glycoprotein in human tumor cell lines by a monoclonal antibody established against a recombinant human endogenous retrovirus-K envelope-gene-encoded protein. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Detection of a 67-kD glycoprotein in human tumor cell lines by a monoclonal antibody established against a recombinant human endogenous retrovirus-K envelope-gene-encoded protein.

Exp Clin Immunogenet. 1995;12(2):96-102. Unique Identifier : AIDSLINE MED/96100697
Vogetseder W; Feng J; Haibach C; Mayerl W; Dierich MP; Institut fur Hygiene, Leopold-Franzens-Universitat Innsbruck,; Osterreich.


Abstract: Endogenous retroviruses in humans are discussed as putative etiologic agents in tumorigenesis. Molecular mimicry of cellular epitopes by retroviruses may be of importance for the genesis of autoimmune diseases. A group of human endogenous retroviruses, HERV-K, which is related to the mouse mammary tumour virus, has been characterised previously and open reading frames have been found covering their gag, pol, prt and env genes. Transcription of HERV-K genomes at the mRNA level as well as antibodies in human sera directed against HERV-K env have been detected recently. We have generated a monoclonal antibody (mAb), anti-HERV1, against a recombinant HERV-K Env protein. This mAb is capable of immunoprecipitating a 67-kD glycoprotein from the human breast carcinoma cell line T47D, the amount of which is strongly enhanced after stimulation with estradiol followed by progesterone. The same band could be precipitated from other carcinoma cell lines (Hep2, MCF7 and HeLa), but not from the human B-lymphoblastoid cell line Raji and from cultured human fibroblasts. Incubation of this antigen in the presence of endoglycosidase F indicates the presence of N-linked carbohydrate moieties of at least 7-9 kD.
Keywords: Animal Antibodies, Monoclonal/BIOSYNTHESIS/*CHEMISTRY Carbohydrate Conformation Gene Products, env/CHEMISTRY/*IMMUNOLOGY Genes, env/IMMUNOLOGY Human Mice Mice, Inbred BALB C Molecular Weight Precipitin Tests Recombinant Proteins/IMMUNOLOGY Retroviridae/GENETICS/*IMMUNOLOGY Support, Non-U.S. Gov't Tumor Cells, Cultured/*IMMUNOLOGY JOURNAL ARTICLEKWDanimalantibodies,monoclonal/biosynthesis/KWDchemistrycarbohydrateconformationgeneproducts,env/chemistry/KWDimmunologygenes,env/immunologyhumanmicemice,inbredbalbcmolecularweightprecipitintestsrecombinantproteins/immunologyretroviridae/genetics/KWDimmunologysupport,non-uKWDsKWDgov'ttumorcells,cultured/KWDimmunologyjournalarticle
960228
M9621042

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .